Benzinga - by Lisa Levin, Benzinga Editor.
Diebold Nixdorf Incorporated (NYSE: DBD) reported an increase in sales for the third quarter on Thursday.
Diebold reported third-quarter net sales of $943.4 million, which rose 16.4% Y/Y. Revenue increased by 17.1% on Non-GAAP basis to $943.3 million. The company registered an adjusted EBITDA of $109.1 million in Q3, higher than $75.6 million a year ago.
Diebold shares fell 3.2% to trade at $20.72 on Friday.
These analysts made changes to their price targets on Diebold following earnings announcement.
- Wedbush raised the price target on Diebold from $20 to $25. Wedbush analyst Matt Bryson maintained a Neutral rating.
- DA Davidson increased the price target on Diebold from $25 to $29. DA Davidson analyst Matthew Summerville upgraded the stock from Neutral to Buy.
Latest Ratings for DBD
Jun 2021 | Wedbush | Initiates Coverage On | Neutral | |
Jan 2021 | JP Morgan | Upgrades | Neutral | Overweight |
May 2020 | JP Morgan | Upgrades | Underweight | Neutral |
View the Latest Analyst Ratings
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.